COLORECTAL CANCER - CETUXIMAB

NICE Appraisal

TA176  Cetuximab for the first line treatment of metastatic colorectal cancer (August 2009)

 

DSU Reports

Cetuximab for the first line treatment of metastatic colorectal cancer: addendum (May 2009)

Cetuximab for the first line treatment of metastatic colorectal cancer (March 2009)

 

To receive notification when new reports or documents are uploaded to this website, please join our mailing list by entering your details on the right of this page or follow us on Twitter @NICE_DSU